EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW 8,410.00
+90.00 (1.08%)
Sep 18, 2026, 3:30 PM KST
EuBiologics Market Cap
EuBiologics has a market cap or net worth of 309.09 billion as of September 18, 2026. Its market cap has decreased by -39.42% in one year.
Market Cap
309.09B
Enterprise Value
n/a
Revenue
96.04B
Ranking
n/a
PE Ratio
12.43
Stock Price
8,410.00
ChartMarket Cap Chart
Since January 24, 2017, EuBiologics's market cap has increased from 122.86B to 309.09B, an increase of 151.58%. That is a compound annual growth rate of 10.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 309.09B | -25.81% |
| Dec 30, 2025 | 416.60B | -6.15% |
| Dec 30, 2024 | 443.89B | 6.16% |
| Dec 28, 2023 | 418.14B | 28.91% |
| Dec 29, 2022 | 324.36B | -74.49% |
| Dec 30, 2021 | 1.27T | 93.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ildong Pharmaceutical | 451.19B |
| Bukwang Pharmaceutical | 395.15B |
| Dong-A ST | 341.69B |
| JW Holdings | 299.60B |
| Hyundai Pharmaceutical | 278.71B |
| Korea United Pharm | 256.22B |
| Humedix | 255.94B |
| Huons | 229.54B |